Varga J, Abraham D (2007) Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 117:557–567
CAS PubMed PubMed Central Article Google Scholar
Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ, Kuwana M, Yasuoka H et al (2005) Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 118:2–10
Jacobsen S, Halberg P, Ullman S (1998) Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma). Br J Rheumatol 37:750–755
CAS PubMed Article Google Scholar
Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69(10):1809–1815
Noureldine HA, Nour-Eldine W, Hodroj MH, Noureldine MHA, Taher A, Uthman I (2020) Hematological malignancies in connective tissue diseases. Lupus 29(3):225–235
CAS PubMed Article Google Scholar
Volkmann ER, Fischer A (2021) Update on morbidity and mortality in systemic sclerosis–related interstitial lung disease. J Scleroderma Relat Disord 6(1):11–20
Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A et al (2017) Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis 76(11):1897–1905
Rubio-Rivas M, Royo C, Simeón CP, Corbella X, Fonollosa V (2014) Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 44(2):208–219
Rosenthal AK, McLaughlin JK, Gridley G, Nyrén O (1995) Incidence of cancer among patients with systemic sclerosis. Cancer 76:910–914
CAS PubMed Article Google Scholar
Abu-Shakra M, Guillemin F, Lee P (1993) Cancer in systemic sclerosis. Arthritis Rheum 36:460–464
CAS PubMed Article Google Scholar
Roumm AD, Medsger TA Jr (1985) Cancer and systemic sclerosis. An epidemiologic study Arthritis Rheum 28:1336–1340
CAS PubMed Article Google Scholar
Olesen AB, Svaerke C, Farkas DK, Sørensen HT (2010) Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study. Br J Dermatol 163(4):800–806
CAS PubMed Article Google Scholar
Partouche L, Goulabchand R, Maria ATJ, Rivière S, Jorgensen C, Rigau V et al (2020) Biphasic temporal relationship between cancers and systemic sclerosis: a clinical series from Montpellier University Hospital and Review of the Literature. J Clin Med 9(3):853
PubMed Central Article Google Scholar
Schottenfeld D, Beebe-Dimmer J (2006) Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 56:69–83
Roberts-Thomson PJ, Male DA, Walker JG, Cox SR, Shen X, Smith MD et al (2004) Genomic instability in scleroderma. Asian Pac J Allergy Immunol 22:153–158
Leone G, Pagano L, Ben-Yehuda D, Voso MT (2007) Therapy-related leukemia and myelodysplasia: susceptibility and incidence. Haematologica 92:1389–1398
CAS PubMed Article Google Scholar
Szekanecz E, Szamosi S, Gergely L, Keszthelyi P, Szekanecz Z, Szucs G (2008) Incidence of lymphoma in systemic sclerosis: a retrospective analysis of 218 Hungarian patients with systemic sclerosis. Clin Rheumatol 27(9):1163–1166
Rosenthal AK, McLaughlin JK, Linet MS, Persson I (1993) Scleroderma and malignancy: an epidemiological study. Ann Rheum Dis 52:531–533
CAS PubMed PubMed Central Article Google Scholar
Morrisroe KB, Hansen D, Huq M, Stevens W, Sahhar J, Ngian GS et al (2020) Incidence, Risk factors, and outcomes of cancer in systemic sclerosis. Arthritis Care Res (Hoboken) 72(11):1625–1635
Marincola FM, Wang E, Herlyn M, Seliger B, Ferrone S (2003) Tumors as elusive targets of T-cell-based active immunotherapy. Mechanisms of Immune Evasion by Tumors. Trends Immunol 24:334–41
Duncan SC, Winkelmann RK (1979) Cancer and scleroderma. Arch Dermatol 115:950–955
CAS PubMed Article Google Scholar
Hill CL, Nguyen AM, Roder D, Roberts-Thomson P (2003) Risk of cancer in patients with scleroderma: a population-based cohort study. Ann Rheum Dis 62:728–731
CAS PubMed PubMed Central Article Google Scholar
Chatterjee S, Dombi GW, Severson RK, Mayes MD (2005) Risk of malignancy in scleroderma: a population-based cohort study. Arthritis Rheum 52:2415–2424
Derk CT, Rasheed M, Artlett CM, Jiminez SA (2006) A cohort study of cancer incidence in systemic sclerosis. J Rheumatol 33:1113–1116
Wooten M (2008) Systemic sclerosis and malignancy: a review of the literature. South Med J 101(1):59–62
Bonifazi M, Tramacere I, Pomponio G, Gabrielli B, Avvedimento EV, La Vecchia C et al (2013) Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies. Rheumatology (Oxford) 52(1):143–154
Pontifex EK, Hill CL, Roberts-Thomson P (2007) Risk factors for lung cancer in patients with scleroderma: a nested case-control study. Ann Rheum Dis 66(4):551–553
Kaşifoğlu T, Yaşar Bilge Ş, Yıldız F, Özen G, Pehlivan Y, Yılmaz N et al (2016) Risk factors for malignancy in systemic sclerosis patients. Clin Rheumatol 35(6):1529–1533
Siau K, Laversuch CJ, Creamer P, O’Rourke KP (2011) Malignancy in scleroderma patients from south west England: a population-based cohort study. Rheumatol Int 31:641–645
Onishi A, Sugiyama D, Kumagai S, Morinobu A (2013) Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies. Arthritis Rheum 65(7):1913–1921
Zhong H, Zhou J, Zhang S, Xu Y, Hou Y, Li M et al (2021) Risk and prognosis factors for systemic sclerosis with lung cancer: a single-centre case-control study in China. Int J Clin Pract 75(4):e13819
Chen M, Liu X, Xu Y, Zhou Q, Shi Y, Zhang D et al (2020) Clinicopathological characteristics of lung cancer in patients with systemic sclerosis. Clin Respir J 14(12):1131–1136
CAS PubMed Article Google Scholar
Colaci M, Giuggioli D, Sebastiani M, Manfredi A, Vacchi C, Spagnolo P et al (2013) Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. Autoimmun Rev 12:374–379
Catano J, Guedon A, Riviere S, Carrat F, Mahevas T, Fain O et al (2019) Cancers in systemic Sclerosis: risk factors, impact on survival and literature review. Rev Med Interne 40(10):637–644
CAS PubMed Article Google Scholar
Kuo CF, Luo SF, Yu KH, Chou IJ, Tseng WY, Chang HC et al (2012) Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan. Scand J Rheumatol 41(1):44–49
Peters-Golden M, Wise RA, Hochberg M, Stevens MB, Wigley FM (1985) Incidence of lung cancer in systemic sclerosis. J Rheumatol 12:1136–1139
Szekanecz E, Szamosi S, Horvàth A, Németh A, Juhàsz B, Szàntò J et al (2012) Malignancies associated with systemic sclerosis. Autoimmun Rev 11(12):852–855
CAS PubMed Article Google Scholar
Peng H, Wu X, Wen Y, Li C, Lin J, Li J et al (2020) Association between systemic sclerosis and risk of lung cancer: results from a pool of cohort studies and Mendelian randomization analysis. Autoimmun Rev 19(10):102633
Colaci M, Giuggioli D, Vacchi C, Lumetti F, Iachetta F, Marcheselli L et al (2014) Breast cancer in systemic sclerosis: results of a cross-linkage of an Italian Rheumatologic Center and a population-based cancer registry and review of the literature. Autoimmun Rev 13:132–137
Maria ATJ, Partouche L, Goulabchand R, Rivière S, Rozier P, Bourgier C et al (2019) Intriguing relationships between cancer and systemic sclerosis: role of the immune system and other contributors. Front Immunol 10(9):3112
Launay D, Le Berre R, Hatron PY, Peyrat JP, Hachulla E, Devulder B et al (2004) Association between systemic sclerosis and breast cancer: eight new cases and review of the literature. Clin Rheumatol 23(6):516–522
Talbott JH, Barrocas M (1979) Progressive systemic sclerosis (PSS) and malignancy, pulmonary and non-pulmonary. Medicine (Baltimore) 58:182–207
Forbes AM, Woodrow JC, Verbov JL, Graham RM (1989) Carcinoma of breast and scleroderma: four further cases and a literature review. Br J Rheumatol 28:65–69
CAS PubMed Article Google Scholar
Bielefeld P, Meyer P, Caillot D, Dalac S, Camus P, Tavernier C et al (1996) Systemic scleroderma and cancers: 21 cases and review of the literature (in French). Rev Med Interne 17:810–813
留言 (0)